Jefferies Assumes Anthera Pharma (ANTH) at Buy

February 19, 2016 6:43 AM EST Send to a Friend
Jefferies assumes coverage on Anthera Pharma (NASDAQ: ANTH) with a Buy rating and a price target of $9.00 (from $12.00).Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login